Esperion Therapeutics (ESPR) Fails to deliver data

Key failure to deliver metrics for Esperion Therapeutics:

• Last SEC data release: 2025-01-31
• Last 15 days FTD volume: £3.46 M
• Last 3 months FTD volume: £5.29 M
• Last year FTD volume: £5.29 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Esperion Therapeutics (ESPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Esperion Therapeutics (ESPR) - since 2013

Esperion Therapeutics (ESPR) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Ultragenyx RARE	£2.03 M	£6.04 M	🇺🇸 USA
BioMarin Pharmaceutical BMRN	£10.27 M	£24.62 M	🇺🇸 USA
Pfizer PFE	£21.73 M	£0.33 B	🇺🇸 USA
Regeneron Pharmaceuticals REGN	£11.46 M	£37.11 M	🇺🇸 USA
Amicus Therapeutics FOLD	£0.63 M	£5.54 M	🇺🇸 USA
Lexicon Pharmaceuticals LXRX	£1.41 M	£16.03 M	🇺🇸 USA